RecruitingNCT06172491

Automating Delirium Severity in the ICU

Harnessing the Power of Technology to Transform Delirium Severity Measurement in the ICU


Sponsor

Mayo Clinic

Enrollment

400 participants

Start Date

Jan 15, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools in ICU patients \>50 years of age. The main questions it aims to answer are: * Is the trained convolutional neural network able to reliably measure delirium severity. * Is the Passive Digital Marker able to accurately measure delirium severity * Is the Passive Digital Marker acceptable and usable by frontline ICU nurse clinicians, patients, and their identified proxies (i.e., caregivers). Participants will: * Study participation involves a video camera recording you 24 hours per day while you are a patient in the Intensive Care Unit (ICU). * Study staff will visit you 4 times each day you are in the ICU. You will be asked questions each time they visit to train the digital marker and see differences between assessments and camera data.


Eligibility

Min Age: 50 Years

Inclusion Criteria2

  • Estimated length of stay >24 hours in ICU; and
  • Are not admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.

Exclusion Criteria3

  • Admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.
  • Admitted for acute neuronal injury
  • Unable to communicate with research team due to sensory deficits (aphasic, blind, deaf) or language (does not speak English)

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06172491


Related Trials